DrugPatentWatch Database Preview
JANSSEN PRODS Company Profile
What is the competitive landscape for JANSSEN PRODS, and when can generic versions of JANSSEN PRODS drugs launch?
JANSSEN PRODS has seven approved drugs.
There are thirty-three US patents protecting JANSSEN PRODS drugs.
There are nine hundred and eleven patent family members on JANSSEN PRODS drugs in sixty-six countries and one hundred and forty-three supplementary protection certificates in thirteen countries.
Summary for JANSSEN PRODS
| International Patents: | 911 |
| US Patents: | 33 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 7 |
Drugs and US Patents for JANSSEN PRODS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Prods | SYMTUZA | cobicistat; darunavir ethanolate; emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 210455-001 | Jul 17, 2018 | RX | Yes | Yes | 8,597,876 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Janssen Prods | PREZISTA | darunavir ethanolate | TABLET;ORAL | 021976-004 | Dec 18, 2008 | RX | Yes | No | 8,518,987*PED | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Janssen Prods | PREZISTA | darunavir ethanolate | TABLET;ORAL | 021976-005 | Dec 18, 2008 | RX | Yes | No | 8,597,876*PED | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for JANSSEN PRODS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen Prods | PREZISTA | darunavir ethanolate | TABLET;ORAL | 021976-002 | Feb 25, 2008 | 5,843,946*PED | ➤ Try a Free Trial |
| Janssen Prods | PREZISTA | darunavir ethanolate | TABLET;ORAL | 021976-004 | Dec 18, 2008 | 5,843,946*PED | ➤ Try a Free Trial |
| Janssen Prods | PREZISTA | darunavir ethanolate | TABLET;ORAL | 021976-006 | Nov 9, 2012 | RE43802*PED | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for JANSSEN PRODS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 800 mg | ➤ Subscribe | 2013-05-14 |
International Patents for JANSSEN PRODS Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2009062383 | ➤ Try a Free Trial |
| Japan | 2014528924 | ➤ Try a Free Trial |
| New Zealand | 594214 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for JANSSEN PRODS Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2016043 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: RILPIVIRINO HIDROCHLORIDAS + TENOFOVIRO ALAFENAMIDAS; REGISTRATION NO/DATE: EU/1/16/1112 20160621 |
| 2015 00054 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: KOMBINATION AF RILPIVIRIN ELLER ETN TERAPEUTISK AEKVIVALENT FORM DERAF, SOM ER BESKYTTET AF GRUNDPATENTET, SASOM ET FARMACEUTISK ACCEPTABELT SALT AF RILPIVIRIN, HERUNDER HYDROCHLORIDSALTET AF RILPIVIRIN, OG EMTRICITABIN; REG. NO/DATE: EU/1/11/737/001-002 20111128 |
| 853 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: COMBINAISON DE RILPIVIRINE OU UNE FORME THERAPEUTIQUE EQUIVALENTE QUI EN DERIVE TELLE QUE PROTEGEE PAR LE BREVET DE BASE, TEL QU'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE RILPIVIRINE, INCLUANT LE SEL CHLORHYDRATE DE RILPIVIRINE ET L'EMTRICITABINE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
